Store
In Vitro Diagnostics Business Outlook, 2024
Publication Date: December 20, 2024
Tags: Growth Rates, Immunoassay, In Vitro Diagnostics (IVD), Market Share, Market Size
Pages: Varies (average 30 pages)
SKU: 24-014
In Vitro Diagnostics Business Outlook, 2024 is a must-have publication offering exclusive information and data that cannot be found elsewhere. With a focus on the in vitro diagnostics (IVD) market, this publication provides valuable insights to help businesses identify growth opportunities, understand market trends, and tailor strategies for success.
Key Features:
- Market data and forecasts: Gain access to growth rates, market size, market share, and more to identify growth opportunities in the IVD market.
- Comprehensive view of the IVD market: Explore various test categories covered and company briefs to stay informed about the latest developments in the industry.
- M&A activities and partnerships: Stay updated on mergers and acquisitions, selected partnerships, collaborations, and other deals shaping the IVD market landscape.
- Industry & region watch: Tailor your strategies with insights into industry trends and regional developments affecting the IVD market.
- Analysis of news and events: Get in-depth analysis of news and events impacting the IVD market, including reporting on news not easily available elsewhere.
Publication Frequency:
Bimonthly (Six Issues Annually)
Why Choose In Vitro Diagnostics Business Outlook, 2024:
- Exclusive market insights: Access information and data that you cannot find anywhere else, helping you stay ahead of the competition.
- Tailored strategies: Use the insights provided to tailor your business strategies and make informed decisions.
- Comprehensive coverage: Get a comprehensive view of the IVD market, including market data, company briefs, M&A activities, and industry news.
Subscribe Now!
Don’t miss out on the valuable insights offered by In Vitro Diagnostics Business Outlook, 2024. Subscribe now to receive bimonthly issues and stay informed about the latest trends and developments in the IVD market.
Table: Global Lab-Based Immunoassay Market, by Segment, 2023-2028 ($ millions)
| 2023 | % Mkt | 2028 | % Mkt | CAGR | |
| Allergy | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Anemia | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Autoimmune | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Blood Bank Screening | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Cardiac Markers | $XX Million | $XX Million | $XX Million | XX% | XX% |
| COVID-19 | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Diabetes/HbA1c | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Fertility | $XX Million | $XX Million | $XX Million | XX% | XX% |
| HAIs/Sepsis | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Hepatitis | $XX Million | $XX Million | $XX Million | XX% | XX% |
| HIV | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Lyme disease | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Mycology | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Parasitology | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Proteins | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Respiratory (excl. COVID) | $XX Million | $XX Million | $XX Million | XX% | XX% |
| STD | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Therapeutic Drugs | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Thyroid | $XX Million | $XX Million | $XX Million | XX% | XX% |
| ToRCH | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Tox/Drug of Abuse | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Tumor Markers | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Vitamin D | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Other Infectious Disease | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Others Non-Infectious Disease | $XX Million | $XX Million | $XX Million | XX% | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Volume 3, Issue 1 – Focus on Molecular HLA Testing
Market Analysis: Molecular HLA/Transplant Testing
Overview of Molecular HLA/Transplant Testing
Market Outlook
Regional Market
Top Company Briefs
Immucor
Luminex/DiaSorin
CareDx
Thermo Fisher Scientific
Executive News Briefing
DEKFI Diagnostics Appoint New CEO
Onera Raises $32 Million in Funding
Cleveland Diagnostics Completes $75 Million in Funding
Financial Highlights: Agilent and Hologic
Agilent Full Year Fiscal 2023 Sales up 1.5% in Core Business YOY
- Figure: Agilent Sales, by Business (Agilent CrossLab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), FY 2022 and FY 2023
- Figure: Agilent Sales, by Business (Agilent CrossLab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), FY 2023 Quarterly Performance
- Table: Agilent Revenue Mix, by Type (Consumables/Services/Informatics and Instruments), FY 2023 (%)
- Figure: Agilent FY 2023 Regional Sales Breakdown Distribution, by Region (Americas, Asia Pacific, Europe) (%)
Hologic Supports Strong Financial Performance in Full-Year Fiscal Year Guidance
- Table: Hologic Diagnostic Sales Performance, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), FY 2023 ($ millions)
- Figure: Hologic Revenue, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), FY 2022 and FY 2023 ($ millions)
- Figure: Hologic Geographic Revenue Distribution, by Region (Asia Pacific, Europe, United States, All Others), FY 2023 (%)
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Mergers and Acquisitions
- Table: Selected Diagnostic Market Mergers and Acquisitions Deals
Partnerships and Collaborations
Industry Watch
COVID-19 Update
Region Watch
India
- Figure: India Real GDP Growth, Inflation Rate (consumer prices), 2017-2024
- Figure: India IVD Market Distribution of Sales, by Broad IVD Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care Glucose, Other Segments), 2023 (%)
Saudi Arabia
- Figure: Saudi Arabia Population Pyramid, 2023 and 2053
- Figure: Saudi Arabia Total Annual Liquid Fuels Production and Consumption, 2013-2022 (millions of barrels)
- Figure: Saudi Arabia IVD Market Share, by Broad IVD Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care Glucose, Other Segments), 2023
Broad-based Company Announcements
QuidelOrtho Obtains FDA Nod
Illumina Plans to Divest Grail
Roche to Acquire LumiraDx
QIAGEN Expands Footprint with New Regional Headquarters in Middle East
Volume 3, Issue 2 – Focus on Immunoassay Overview
Market Analysis
Overview of IVD Immunoassay
Market Outlook
- Table: Global Lab-Based Immunoassay Market by Segment, 2023-2028 ($ millions)
- Figure: Global Lab-Based Immunoassay Market, by Segment, 2023-2028 ($ millions)
Regional Market
- Table: Global Immunoassay Market (Lab-Based) Sales Distribution, by Region, 2023 (%) (North America, Europe, Asia Pacific, Latin America, Middle East, Africa)
- Figure: Global Immunoassay Market Sales Distribution, Top 10 Country Markets, 2023 (%)
Top Company Briefs
Roche
Abbott Diagnostics
Siemens Healthineers
Other Selected Immunoassay News
Executive News Briefing
NOWDiagnostics Selects New Science Officer
Freenome Raises $254 Million in New Funding
QuidelOrtho Axes CEO
Agilent CEO to Retire
Financial Highlights: Bio-Rad Laboratories and Veracyte
Bio-Rad Laboratories Reports Full-Year 2023 Clinical Diagnostics Revenues up 3.2% over previous year
- Table: Bio-Rad Laboratories Net Sales, 2021-2023 ($M)
- Figure: Bio-Rad Laboratories’ Sales by Business, 2022 vs. 2023, $M
- Figure: Bio-Rad Laboratories Quarterly Performance by Business, 2022 vs. 2023 ($M)
- Figure: Bio-Rad Laboratories 2022 and 2023 Regional Sales Breakdown Distribution
Veracyte Reported Strong Performance in 2023
- Figure: Veracyte 12-Month (FY22 and FY23) Sales by Division (Testing, Product, Biopharmaceutical and Other), Thousands USD
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Mergers and Acquisitions
- Table: Selected Diagnostic Market Mergers and Acquisitions Deals
Partnerships and Collaborations
Industry Watch
Virus Testing Update
Region Watch
Peru
- Figure: Peru Population Distribution by Broad Age Group, 2023 and 2040 Estimates
- Figure: Peru GDP Value and Growth by Year, 2010-2022
- Figure: Peru COVID-19 Lab Samples Tested and Positivity by Region, Cumulative 2020-2023
South Africa
- Figure: South Africa Population Pyramid, 2023 and 2033 Estimates
- Figure: South Africa GDP, Composition by Sector (Agriculture, Industry, Services)
Broad-based Company Announcements
Werfen Receives CE Mark for Aptiva Antiphospholipid Syndrome
DiaSorin Nabs FDA Clearance for New LIAISON PLEX System
T2 Biosystems Offers Expanded Panel
Cepheid Received FDA Clearance for Xpert Xpress GBS
DiaCarta Collaboration to Launch Prostate Cancer LDT
Volume 3, Issue 3 – Clinical Chemistry
Market Analysis: Clinical Chemistry
Overview of Clinical Chemistry Market
Market Outlook
- Table: Clinical Chemistry Diagnostic Sales, by Broad Test Category, 2023 ($ millions)
- Figure: Clinical Chemistry Diagnostic Market Distribution, by Broad Test Category, 2023 (%)
Major Product Activity
- Lab-based Clinical Chemistry
- Table: Market Summary: Lab-based Clinical Chemistry Market, by Segment, 2023 and 2028 ($ millions)
- Point-of-Care Clinical Chemistry
- Table: Market Summary: POC-based Clinical Chemistry Market, 2023 and 2028 ($ millions)
Regional Market
- Figure: Global Clinical Chemistry Sales Estimates and Projection, by Region, 2023 and 2028 ($ millions)
- Table: Global Clinical Chemistry Sales Distribution, by Region, 2023 (%)
Top Company Briefs
Roche
Abbott
Danaher
Executive News Briefing
Cue Health Calls It Quits
Allenz Health Secures $60 Million in Funding
Next Gen Diagnostics Welcomes New Scientific Advisory Board Member
Next Gen Diagnostics Opens First U.S. Laboratory
Financial Highlights: bioMérieux & Sekisui Diagnostics
- Figure: bioMérieux Sales Distribution, by Business Segment, 2023 (%)
- Table: bioMérieux Financial Review, by Business Segment, FY 2022 – FY 2-23 (€M)
- Figure: bioMérieux FY 2022 vs FY 2023 Regional Sales Breakdown (€M)
- Table: Sekisui Chemical Financial Results, FY 2022 and FY 2023 (Billions of Yen)
- Table: Sekisui Chemical Annual Overview and Focus, FY 2023 and FY 2024 (Billions of Yen)
- Table: Sekisui Chemical Net Sales, by Segment, FY22 and FY23 (Billions of Yen)
- Figure: Sekisui Chemical Medical Division, Revenue Mix, by Type, by Quarter, Q1 FY22 – Q4FY23 (Millions of Yen)
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Mergers and Acquisitions
- Table: Selected Diagnostic Market Mergers and Acquisitions Deals
Partnerships and Collaborations
Industry Watch
COVID-19/Flu Update
Region Watch
Japan
- Figure: Japan National Health Expenditures, Year-on-Year Growth Rate, 1985-2019 (Yen trillion, %)
- Figure: Japan: Changes in Number of Hospitals, by Hospital Type, 2015-2019
- Figure: Japan: Changes in Number of Beds, by Bed Type and Number of Beds per Hospital, 2015-2019
- Figure: Japan: Changes in Average Length of Stay, by Bed Type, 2015-2019
- Figure: Japan IVD Market, by Segment, 2023 (%)
Broad-based Company Announcements
Announcements
QIAGEN Launches Gastrointestinal Molecular Panel in the United States
Illumina Spins Off Grail
QIAGEN Discontinues NeuMoDx System
DiaSorin Nabs Clearance for LIAISON PLEX Blood Culture Yeast Assay
Genetic Signatures Granted FDA Clearance for GI Kit
Related products
Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
November 29, 2023
In recent decades, genetic technologies for research and diagnostics have transformed healthcare, offering new possibilities in precision medicine and disease management. Next-generation sequencing (NGS) has revolutionized genetic disease diagnostics and oncology, providing comprehensive insights at a relatively low cost. PCR continues to evolve, remaining a central tool in molecular diagnostics. In situ hybridization techniques (ISH)…
Price range: $5,000.00 through $7,500.00
Hematology and Coagulation Markets, 2023
April 5, 2023
Discover the lucrative $10 billion-dollar market for hematology and coagulation in vitro diagnostic (IVD) testing with Kalorama’s comprehensive report, Hematology and Coagulation Markets, 2023. This analysis delves into the dynamic growth factors driving this market, including new technologies, the aging population, and the increasing demand for decentralized testing.
Key Insights Provided:
- Market sizing…
Price range: $3,000.00 through $4,500.00
Cell and Gene Therapy Market and Deals Analysis, 2023
May 22, 2023
Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals tracks deal-making and market opportunities in cell and gene therapy, providing specific details of 1000+ deals from 2022-2023. With a staggering $40 billion in CGT deals in 2022 alone, understanding the market dynamics and key…
Price range: $4,000.00 through $6,000.00
